Lumos Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2009
Net Income	-34.03	-31.06	-30.43	-6.31	-12.75	-53.6	-71.95	-85.16	-40.38	96.02	Upgrade
Depreciation & Amortization	0.04	0.05	0.22	0.58	0.04	1.15	1.41	2.08	1.59	1.1	Upgrade
Share-Based Compensation	2.32	2.32	2.88	1.07	0.18	17.12	18.51	16.71	15.94	8.61	Upgrade
Other Operating Activities	0.57	2.07	-2.31	-18.99	0.4	-2.61	3.76	0.42	-1.24	3.34	Upgrade
Operating Cash Flow	-31.1	-26.62	-29.65	-23	-9.09	-37.94	-48.28	-65.95	-24.09	109.07	Upgrade
Capital Expenditures	0	-0.02	-0.03	32.47	-0	0.12	0.21	-2.25	-4	-1.7	Upgrade
Acquisitions	0	0	0	84.18	0	0	0	0	0	0	Upgrade
Change in Investments	10.74	-11.34	0	0	0	0	0	2.18	10.21	-12.14	Upgrade
Other Investing Activities	-	-	26	-	-	-	-	-	-	-	Upgrade
Investing Cash Flow	10.74	-11.36	25.97	116.65	-0	0.12	0.21	-0.07	6.22	-13.84	Upgrade
Share Issuance / Repurchase	-0.55	-0.59	-0.08	0.1	0.02	0.02	75.53	2.14	17.18	29.68	Upgrade
Debt Issued / Paid	0	0	0	-0.03	0	-0.17	-0.25	-0.26	-0.19	-0.09	Upgrade
Other Financing Activities	-0.03	-0.24	-0.11	-	-	-	-	-	6.1	4.3	Upgrade
Financing Cash Flow	-0.58	-0.82	-0.19	0.08	0.02	-0.15	75.29	1.88	23.09	33.89	Upgrade
Net Cash Flow	-20.93	-38.8	-3.87	93.73	-9.07	-37.97	27.22	-64.13	5.22	129.11	Upgrade
Free Cash Flow	-31.1	-26.64	-29.68	9.47	-9.09	-37.82	-48.07	-68.19	-28.08	107.37	Upgrade
Free Cash Flow Margin	-1516.09%	-1749.44%	-12903.48%	5638.69%	-	-303.21%	-167.43%	-190.65%	-41.00%	62.21%	Upgrade
Free Cash Flow Per Share	-3.82	-3.18	-3.56	1.40	-6.98	-9.15	-13.82	-21.18	-8.84	34.71	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).